Target intelligence / Profile preview

I-kappa B kinase beta (IKK-beta)

Target
IKK-beta
Molecular classification
Enzyme, Serine/threonine protein kinase
01

Overview

I-kappa B kinase beta (IKK-beta) is a serine/threonine protein kinase and a key component of the IKK complex, which also includes IKK-alpha and NEMO. The IKK complex plays a central role in the canonical NF-kappa B signaling pathway. IKK-beta phosphorylates IκB proteins, leading to their ubiquitination and degradation, which in turn allows NF-kappa B dimers to translocate to the nucleus and activate gene transcription. This pathway is critical for immune responses, inflammation, and cell survival. IKK-beta is activated by pro-inflammatory stimuli such as TNF-alpha, IL-1, and LPS. Due to its role in inflammation and cancer, IKK-beta is a therapeutic target for inflammatory diseases, autoimmune disorders, and cancer.

Other names
IKK-βIKBKBInhibitor of nuclear factor kappa-B kinase subunit beta
02

Mechanism of action

Inhibition of IKK-beta leads to reduced phosphorylation of IκB proteins, preventing NF-kappa B activation and subsequent transcription of inflammatory and pro-survival genes.

03

Biological functions

Signal transductionImmune responseInflammationCell survivalRegulation of NF-kappa B pathway
04

Disease associations

CancerInflammationAutoimmune disordersNeuroprotection after stroke
05

Safety considerations

Potential for immunosuppressionOff-target effects due to kinase promiscuity

Beyond the preview

Go deeper on I-kappa B kinase beta (IKK-beta).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on I-kappa B kinase beta (IKK-beta).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call